Walsh JK, Coulouvrat C, Hajak G, Lakoma MD, Petukhova M, Roth T, Sampson NA, Shahly V, Shillington A, Stephenson JJ, Kessler RC (2011) Nighttime insomnia symptoms and perceived health in the America Insomnia Survey (AIS). Sleep 34(8):997–1011. https://doi.org/10.5665/sleep.1150
Article PubMed PubMed Central Google Scholar
Morin CM, Jarrin DC (2022) Epidemiology of insomnia: prevalence, course, risk factors, and public health burden. Sleep Med Clin 17(2):173–191. https://doi.org/10.1016/j.jsmc.2022.03.003
Perlis ML, Vargas I, Ellis JG, Grandner MA, Morales KH, Gencarelli A, Khader W, Kloss JD, Gooneratne NS, Thase ME (2020) The natural history of insomnia: the incidence of acute insomnia and subsequent progression to chronic insomnia or recovery in good sleeper subjects. Sleep 43(6):zsz299. https://doi.org/10.1093/sleep/zsz299
Ellis JG, Perlis ML, Neale LF, Espie CA, Bastien CH (2012) The natural history of insomnia: focus on prevalence and incidence of acute insomnia. J Psychiatr Res 46(10):1278–1285. https://doi.org/10.1016/j.jpsychires.2012.07.001
Roth T (2007) Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 3(5 suppl):S7–S10
Article PubMed PubMed Central Google Scholar
American Psychiatric Association (2022) Diagnostic and statistical manual of mental disorders, Fifth Edition, Text Revision. American Psychiatric Association, Washington, DC
Perlis ML, Smith MT, Cacialli DO, Nowakowski S, Orff H (2003) On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications J Psychosom Res 54(1):51–59. https://doi.org/10.1016/s0022-3999(02)00547-0
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 13(2):307–349. https://doi.org/10.5664/jcsm.6470
Article PubMed PubMed Central Google Scholar
Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D (2015) Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med 163(3):191–204. https://doi.org/10.7326/m14-2841
Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 165(2):125–133. https://doi.org/10.7326/m15-2175
Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL (2021) Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 17(2):255–262. https://doi.org/10.5664/jcsm.8986
Article PubMed PubMed Central Google Scholar
Perlis ML, Pigeon WR, Grandner MA, Bishop TM, Riemann D, Ellis JG, Teel JR, Posner DA (2021) Why treat insomnia? J Prim Care Community Health 12:21501327211014084. https://doi.org/10.1177/21501327211014084
Article PubMed PubMed Central Google Scholar
Agnew S, Vallières A, Hamilton A, McCrory S, Nikolic M, Kyle SD, Fleming L, Crawford MR (2021) Adherence to cognitive behavior therapy for insomnia: an updated systematic review. Sleep Med Clin 16(1):155–202. https://doi.org/10.1016/j.jsmc.2020.11.002
Madari S, Golebiowski R, Mansukhani MP, Kolla BP (2021) Pharmacological management of insomnia. Neurotherapeutics 18(1):44–52. https://doi.org/10.1007/s13311-021-01010-z
Article PubMed PubMed Central Google Scholar
Asnis GM, Thomas M, Henderson MA (2015) Pharmacotherapy treatment options for insomnia: a primer for clinicians. Int J Mol Sci 17(1):50. https://doi.org/10.3390/ijms17010050
Article CAS PubMed PubMed Central Google Scholar
Ambien [package insert] (2022) Bridgewater, NJ: sanofi-aventis U.S.; February 2022
Belsomra [package insert] (2023) Rahway, NJ: Merck Sharp & Dohme; February 2023
Dayvigo [package insert] (2023) Nutley, NJ: Eisai Inc.; December 2023
Lunesta [package insert] (2019) Marlborough, MA: Sunovion Pharmaceuticals; August 2019
Quviviq [package insert] (2023) Radnor, PA: Idorsia Pharmaceuticals; October 2023
Restoril [package insert] (2023) Bridgewater, NJ: Mallinckrodt Pharmaceuticals; January 2023
Rozerem [package insert] (2021) Lexington, MA: Takeda Pharmaceuticals America; November 2021
Silenor [package insert] (2022) Brentwood, TN: Currax Pharmaceuticals; December 2022
Yeung WF, Chung KF, Yung KP, Ng TH (2015) Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 19:75–83. https://doi.org/10.1016/j.smrv.2014.06.001
Roth T, Heith Durrence H, Jochelson P, Peterson G, Ludington E, Rogowski R, Scharf M, Lankford A (2010) Efficacy and safety of doxepin 6 mg in a model of transient insomnia. Sleep Med 11(9):843–847. https://doi.org/10.1016/j.sleep.2010.07.006
Krystal AD, Lankford A, Durrence HH, Ludington E, Jochelson P, Rogowski R, Roth T (2011) Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia. Sleep 34(10):1433–1442. https://doi.org/10.5665/sleep.1294
Article PubMed PubMed Central Google Scholar
Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T (2010) Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 33(11):1553–1561. https://doi.org/10.1093/sleep/33.11.1553
Article PubMed PubMed Central Google Scholar
Roth T, Seiden D, Wang-Weigand S, Zhang J (2007) A 2-night, 3-period, crossover study of ramelteon’s efficacy and safety in older adults with chronic insomnia. Curr Med Res Opin 23(5):1005–14
Article CAS PubMed Google Scholar
Erman M, Seiden D, Zammit G, Sainati S, Zhang J (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Med 7(1):17–24
Walsh JK, Soubrane C, Roth T (2008) Efficacy and safety of zolpidem extended release in elderly primary insomnia patients. Am J Geriatr Psychiatry 16(1):44–57. https://doi.org/10.1097/JGP.0b013e3181256b01
Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M (2019) Comparison of lemborexant with placebo and zolpidem tartrate extended release for the treatment of older adults with insomnia disorder: a phase 3 randomized clinical trial. JAMA Netw Open 2(12):e1918254. https://doi.org/10.1001/jamanetworkopen.2019.18254
Article PubMed PubMed Central Google Scholar
Dauvilliers Y, Zammit G, Fietze I, Mayleben D, Seboek Kinter D, Pain S, Hedner J (2020) Daridorexant, a new dual orexin receptor antagonist to treat insomnia disorder. Ann Neurol 87(3):347–356. https://doi.org/10.1002/ana.25680
Article CAS PubMed Google Scholar
Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK (2008) A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. J Clin Sleep Med 4(3):229–34
Article PubMed PubMed Central Google Scholar
Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL (2016) Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med 165(2):103–112. https://doi.org/10.7326/m15-1781
Herring WJ, Snyder E, Budd K, Hutzelmann J, Snavely D, Liu K, Lines C, Roth T, Michelson D (2012) Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 79(23):2265–2274. https://doi.org/10.1212/WNL.0b013e31827688ee
Article CAS PubMed Google Scholar
Baker FC, Maloney S, Driver HS (1999) A comparison of subjective estimates of sleep with objective polysomnographic data in healthy men and women. J Psychosom Res 47(4):335–341. https://doi.org/10.1016/s0022-3999(99)00017-3
Comments (0)